Skin metastases of gynecologic adenocarcinomas affect serum levels of hCGβ but not those of SCC antigen

Tumor Biology

Volumn 20, Issue 5, 1999, Pages 251-255

  Lehtovirta, Pentti ^a   Alfthan, Henrik ^a   Vartiainen, Juhani ^a   Stenman, Ulf Håkan ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Gynecologic adenocarcinoma; Human chorionic gonadotropin; Skin metastases; Squamous cell carcinoma antigen

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RESISTANCE; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENDOMETRIUM CARCINOMA; FEMALE; GYNECOLOGIC CANCER; HORMONE BLOOD LEVEL; HUMAN; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN METASTASIS; UTERINE CERVIX CARCINOMA;

EID: 0032764759     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030071     Document Type: Article

References (21)

1. Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VJ, Knapp RC: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309:883-887.
2. Patsner B, Mann WJ, Cohen H, Loesch M: Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma. Am J Obstet Gynecol 1988;158:399-402.
3. Marcillac I, Troalen F, Bidart J-M, Ghillani P, Ribrag V, Escudier B, Malassagne B, Droz J-P, Lhommé C. Rougier P, Duvillard P, Prade M, Lugagne P-M, Richard F, Poynard T, Bohuon C, Wands J, Bellet D: Free human chorionic gonadotropin β subunit in gonadal and nongonadal neoplasms. Cancer Res 1992;52: 3901-3907.
4. Alfthan H, Haglund C, Roberts P, Stenman U-H: Elevation of free β subunit of human choriogonadotropin and core β fragment of human choriogonadotropin in serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 1992;52:4628-4633.
5. Kato H, Torigoe T: Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977;40:1621-1628.
6. Lehtovirta P, Viinikka L, Ylikorkala O: Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix. Gynecol Oncol 1990;37:276-278.
7. Kato H, Morioka H, Tsutsui H, Aramaki S, Torigoe T: Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer. Cancer 1982;50: 1294-1296.
8. Maruo T, Shibata K, Kimura A, Hoshina M, Mochizuki M: Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization. Cancer 1985;56:302-308.
9. Duk JM, de Brujin HW, Groenier KH, Hollema H, ten Hoor KA, Krans M, Aalders JG: Cancer of the uterine cervix: Sensitivity and specificity of serum squamous cell carcinoma antigen determinations. Gynecol Oncol 1990;39:186-194.
10. Kato H, Morioka H, Aramaki S, Tamai K, Torigoe T: Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix. Am J Obstet Gynecol 1983;145:350-354.
11. Senekjian EK, Young JM, Weiser PA, Spencer CE, Magic SE, Herbst AL: An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma. Am J Obstet Gynecol 1987;157: 433-439.
12. Bolli JA, Doering DL, Bosscher JR, Day TJ, Rao CV, Owens K, Kelly B, Goldsmith J: Squamous cell carcinoma antigen: Clinical utility in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1994; 55:169-173.
13. Yagi H, Danno K, Maruguchi Y, Yamamoto M, Imamura S: Significance of squamous cell carcinoma (SCC)-related antigens in cutaneous SCC. A preliminary report. Arch Dermatol 1987;123:902-906.
14. Hara M, Hunayama M, Aiba S, Suetake T, Watanabe M, Tanaka M, Tagami H: Acrokeratosis paraneoplastica (Bazex syndrome) associated with primary cutaneous squamous cell carcinoma of the lower leg, vitiligo and alopecia areata. Br J Dermatol 1995;133:121-124.
15. Fischbach W, Rink C: SCC-Antigen: ein sensitiver und spezifischer Tumormarker für Plattenepithelkarzinome? (in German). Dtsch Med Wochenschr 1988;113:289-293.
16. van der Sijde R, de Bruijn HW, Krans M, Bouma J, Aalders JG: Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva. Gynecol Oncol 1989;35:227-232.
17. Ueda G, Inoue Y, Yamasaki M, Inoue M, Tanaka Y, Hiramatsu K, Saito J, Nishino T, Abe Y: Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors. Int J Gynecol Pathol 1984;3: 291-298.
18. Duk JM, van Voorst Vader PC, ten Hoor KA, Hollema H, Doeglas HM, de Bruijn HW: Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin. Cancer 1989;64:1652-1656.
19. Duk J M, Aalders JG, Fleuren GJ, de Bruijn HW: CA 125: A useful marker in endometrial carcinoma. Am J Obstet Gynecol 1986:155:1097-1102.
20. Rose PG, Sommers RM, Reale FR, Hunter RE, Fournier E, Nelson BE: Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma. Obstet Gynecol 1994;84:12-16.
21. Acevedo HF, Tong JY, Hartsock RJ: Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 1995;76:1467-1475.